Chicos FAS Inc (CHS) Fundamental Analysis & Valuation

NYSE:CHS • US1686151028

7.59 USD
-0.01 (-0.13%)
At close: Jan 4, 2024
7.591 USD
+0 (+0.01%)
After Hours: 1/4/2024, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CHS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Overall CHS gets a fundamental rating of 4 out of 10. We evaluated CHS against 123 industry peers in the Specialty Retail industry. Both the profitability and the financial health of CHS get a neutral evaluation. Nothing too spectacular is happening here. CHS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. CHS Profitability Analysis

1.1 Basic Checks

  • In the past year CHS was profitable.
  • In the past year CHS had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: CHS reported negative net income in multiple years.
  • Of the past 5 years CHS 4 years had a positive operating cash flow.
CHS Yearly Net Income VS EBIT VS OCF VS FCFCHS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M -200M -300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 8.82%, CHS is in the better half of the industry, outperforming 79.84% of the companies in the same industry.
  • CHS has a Return On Equity of 26.40%. This is in the better half of the industry: CHS outperforms 79.84% of its industry peers.
  • With a decent Return On Invested Capital value of 12.31%, CHS is doing good in the industry, outperforming 77.52% of the companies in the same industry.
Industry RankSector Rank
ROA 8.82%
ROE 26.4%
ROIC 12.31%
ROA(3y)-5.09%
ROA(5y)-2.53%
ROE(3y)-55.05%
ROE(5y)-32.32%
ROIC(3y)N/A
ROIC(5y)N/A
CHS Yearly ROA, ROE, ROICCHS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

1.3 Margins

  • Looking at the Profit Margin, with a value of 5.29%, CHS is in the better half of the industry, outperforming 72.87% of the companies in the same industry.
  • CHS's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 6.16%, CHS is in the better half of the industry, outperforming 68.22% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CHS has grown nicely.
  • CHS has a Gross Margin of 38.94%. This is comparable to the rest of the industry: CHS outperforms 59.69% of its industry peers.
  • CHS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.16%
PM (TTM) 5.29%
GM 38.94%
OM growth 3YN/A
OM growth 5Y1.58%
PM growth 3YN/A
PM growth 5Y3.25%
GM growth 3Y4.35%
GM growth 5Y0.65%
CHS Yearly Profit, Operating, Gross MarginsCHS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CHS Health Analysis

2.1 Basic Checks

  • CHS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • CHS has more shares outstanding than it did 1 year ago.
  • CHS has a better debt/assets ratio than last year.
CHS Yearly Shares OutstandingCHS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
CHS Yearly Total Debt VS Total AssetsCHS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 3.22 indicates that CHS is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of CHS (3.22) is better than 70.54% of its industry peers.
  • CHS has a debt to FCF ratio of 0.42. This is a very positive value and a sign of high solvency as it would only need 0.42 years to pay back of all of its debts.
  • CHS has a Debt to FCF ratio of 0.42. This is amongst the best in the industry. CHS outperforms 82.17% of its industry peers.
  • CHS has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.06, CHS is doing good in the industry, outperforming 75.97% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.42
Altman-Z 3.22
ROIC/WACC1.34
WACC9.19%
CHS Yearly LT Debt VS Equity VS FCFCHS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 1.20 indicates that CHS should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.20, CHS is not doing good in the industry: 72.09% of the companies in the same industry are doing better.
  • CHS has a Quick Ratio of 1.20. This is a bad value and indicates that CHS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CHS has a Quick ratio of 0.42. This is in the lower half of the industry: CHS underperforms 60.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 0.42
CHS Yearly Current Assets VS Current LiabilitesCHS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. CHS Growth Analysis

3.1 Past

  • CHS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.38%.
  • The Earnings Per Share has been growing slightly by 4.10% on average over the past years.
  • Looking at the last year, CHS shows a decrease in Revenue. The Revenue has decreased by -0.24% in the last year.
  • The Revenue has been decreasing by -1.26% on average over the past years.
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5Y4.1%
EPS Q2Q%-45%
Revenue 1Y (TTM)-0.24%
Revenue growth 3Y1.67%
Revenue growth 5Y-1.26%
Sales Q2Q%-2.54%

3.2 Future

  • Based on estimates for the next years, CHS will show a decrease in Earnings Per Share. The EPS will decrease by -8.47% on average per year.
  • The Revenue is expected to grow by 0.60% on average over the next years.
EPS Next Y-18.51%
EPS Next 2Y-8.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.79%
Revenue Next 2Y0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CHS Yearly Revenue VS EstimatesCHS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
CHS Yearly EPS VS EstimatesCHS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1 -2

More info and screens

Find the best growth stocksShow best growing peers

6

4. CHS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 9.86, which indicates a very decent valuation of CHS.
  • Compared to the rest of the industry, the Price/Earnings ratio of CHS indicates a somewhat cheap valuation: CHS is cheaper than 79.07% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of CHS to the average of the S&P500 Index (26.29), we can say CHS is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 10.29, the valuation of CHS can be described as reasonable.
  • 74.42% of the companies in the same industry are more expensive than CHS, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 24.57. CHS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.86
Fwd PE 10.29
CHS Price Earnings VS Forward Price EarningsCHS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHS indicates a rather cheap valuation: CHS is cheaper than 85.27% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, CHS is valued a bit cheaper than the industry average as 67.44% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 16.37
EV/EBITDA 4.72
CHS Per share dataCHS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • CHS has a very decent profitability rating, which may justify a higher PE ratio.
  • CHS's earnings are expected to decrease with -8.47% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)2.41
EPS Next 2Y-8.47%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CHS Dividend Analysis

5.1 Amount

  • No dividends for CHS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CHS Fundamentals: All Metrics, Ratios and Statistics

Chicos FAS Inc

NYSE:CHS (1/4/2024, 8:04:00 PM)

After market: 7.591 +0 (+0.01%)

7.59

-0.01 (-0.13%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-30
Earnings (Next)N/A
Inst Owners0.13%
Inst Owner Change0%
Ins Owners3.85%
Ins Owner Change0%
Market Cap937.06M
Revenue(TTM)2.11B
Net Income(TTM)111.58M
Analysts46.67
Price Target7.75 (2.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.66%
Min EPS beat(2)2.68%
Max EPS beat(2)14.64%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.59%
Min Revenue beat(2)-2.73%
Max Revenue beat(2)-2.44%
Revenue beat(4)1
Avg Revenue beat(4)-1.54%
Min Revenue beat(4)-2.73%
Max Revenue beat(4)1.35%
Revenue beat(8)4
Avg Revenue beat(8)0.55%
Revenue beat(12)7
Avg Revenue beat(12)2.48%
Revenue beat(16)7
Avg Revenue beat(16)-0.31%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.23%
Valuation
Industry RankSector Rank
PE 9.86
Fwd PE 10.29
P/S 0.44
P/FCF 16.37
P/OCF 8.25
P/B 2.22
P/tB 2.34
EV/EBITDA 4.72
EPS(TTM)0.77
EY10.14%
EPS(NY)0.74
Fwd EY9.71%
FCF(TTM)0.46
FCFY6.11%
OCF(TTM)0.92
OCFY12.11%
SpS17.08
BVpS3.42
TBVpS3.25
PEG (NY)N/A
PEG (5Y)2.41
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 8.82%
ROE 26.4%
ROCE 15.79%
ROIC 12.31%
ROICexc 14.55%
ROICexgc 15.01%
OM 6.16%
PM (TTM) 5.29%
GM 38.94%
FCFM 2.71%
ROA(3y)-5.09%
ROA(5y)-2.53%
ROE(3y)-55.05%
ROE(5y)-32.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-2.56%
ROICexc growth 3YN/A
ROICexc growth 5Y1.76%
OM growth 3YN/A
OM growth 5Y1.58%
PM growth 3YN/A
PM growth 5Y3.25%
GM growth 3Y4.35%
GM growth 5Y0.65%
F-Score5
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.42
Debt/EBITDA 0.14
Cap/Depr 134.65%
Cap/Sales 2.67%
Interest Coverage 35.98
Cash Conversion 66.14%
Profit Quality 51.32%
Current Ratio 1.2
Quick Ratio 0.42
Altman-Z 3.22
F-Score5
WACC9.19%
ROIC/WACC1.34
Cap/Depr(3y)46.44%
Cap/Depr(5y)47.4%
Cap/Sales(3y)1.18%
Cap/Sales(5y)1.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5Y4.1%
EPS Q2Q%-45%
EPS Next Y-18.51%
EPS Next 2Y-8.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.24%
Revenue growth 3Y1.67%
Revenue growth 5Y-1.26%
Sales Q2Q%-2.54%
Revenue Next Year0.79%
Revenue Next 2Y0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.35%
EBIT growth 3YN/A
EBIT growth 5Y0.3%
EBIT Next Year18.25%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y29.25%
FCF growth 3YN/A
FCF growth 5Y0.2%
OCF growth 1Y108.67%
OCF growth 3Y69.3%
OCF growth 5Y-0.64%

Chicos FAS Inc / CHS FAQ

What is the fundamental rating for CHS stock?

ChartMill assigns a fundamental rating of 5 / 10 to CHS.


What is the valuation status of Chicos FAS Inc (CHS) stock?

ChartMill assigns a valuation rating of 6 / 10 to Chicos FAS Inc (CHS). This can be considered as Fairly Valued.


What is the profitability of CHS stock?

Chicos FAS Inc (CHS) has a profitability rating of 6 / 10.


What is the valuation of Chicos FAS Inc based on its PE and PB ratios?

The Price/Earnings (PE) ratio for Chicos FAS Inc (CHS) is 9.86 and the Price/Book (PB) ratio is 2.22.


Can you provide the dividend sustainability for CHS stock?

The dividend rating of Chicos FAS Inc (CHS) is 0 / 10 and the dividend payout ratio is 0%.